You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
This post has been updated to fix the spelling of Novavax's name.
Vaccine maker Novavax has announced that it has begun a phase III trial of its SARS-CoV-2 vaccine in the UK and plans to begin a US trial next month, the New York Times reports.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?Login Now.
Don't have a GenomeWeb or 360Dx account?Register for Free.
A survey by Nature finds that most researchers want scientific meetings to continue virtually or with a virtual component, even after the pandemic ends.
Bloomberg reports that the B.1.351 SARS-CoV-2 viral variant could prompt the formulation of better vaccines.
Certain blood proteins may be able to distinguish COVID-19 patients who will become critically ill from those who will not, the Atlanta Journal-Constitution reports.
In Genome Biology this week: algorithm to assess regulatory features, approach to integrate multiple single-cell RNA-seq datasets, and more.